Drug Origin Transparency Act of 2026

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 1 History 2 Sponsors

Introduced in House Apr 16, 2026 · 981 words Open full page ↗

119TH CONGRESS

2D SESSION

H. R. 8339

To amend the Federal Food, Drug, and Cosmetic Act to enhance drug

manufacturing amount information reporting, and for other purposes.

Sign in to read the full text

The document summary and details above are public. The full text is available to signed-in accounts.

Create a free account Sign in

PASSAGE PROBABILITY

1% Unlikely

Why this number

Stage base In Committee — base rate 2%, measured from US's completed sessions
Momentum -4 33/100 from the pace of recorded action
Time since last action -22 182 days quiet

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.